Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 16

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 16
---
armaceuticals, Inc. Mr. Carpenter also served as a director of Genzyme Corporation from 1994 to 2010. Mr. Carpenter received his B.S. in engineering from the U.S. Military Academy at West Point, his M.S. in computer science from Stanford University and his M.B.A. from Harvard Business School. We believe that Mr. Carpenter is qualified to serve on our Board of Directors due to his extensive leadership skills and experience in the healthcare and biotechnology industries.

Benjamin J. Zeskind, Ph.D. has served as our Co-Founder, President, Chief Executive Officer and a member of our Board of Directors since February 2008. Dr. Zeskind received his S.B. in electrical engineering and computer science and his Ph.D. in bioengineering from Massachusetts Institute of Technology, or MIT, and his M.B.A. from Harvard Business School, where he was recognized as a Baker Scholar, the highest award for distinction. We believe that Dr. Zeskind is qualified to serve on our Board of Directors due to his extensive experience in the pharmaceutical industry and in-depth knowledge of our business.

<div align='center'>11</div>

TABLE OF CONTENTS

#### Board Recommendation
The Board of Directors unanimously recommends a vote FOR the election of each of Ann E. Berman, Diana F. Hausman and Thomas J. Schall as a Class I director to hold office until the 2028 Annual Meeting and until his or her successor has been duly elected and qualified.

<div align='center'>12</div>

TABLE OF CONTENTS

<div align='center'>PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED</div>

### PUBLIC ACCOUNTING FIRM
Appointment of Independent Registered Public Accounting Firm

The audit committee appoints our independent registered public accounting firm. In this regard, the audit committee evaluates the qualifications, performance and independence of our independent registered public accounting firm and determines whether to re-engage our current firm. As part of its evaluation, the audit committee considers, among other factors, the quality and efficiency of the services provided by the firm, including the performance, technical expertise, industry knowledge and experience of the lead audit partner and the audit team assigned to our account; the overall strength and reputation of the firm; the firm’s global capabilities relative to our business; and the firm’s knowledge of our operations. RSM US LLP (“RSM”) has served as our independent registered public accounting firm since 2020. Neither the